How does this optical biosensor work? We used a monoclonal antibody against an MPXV (monkeypox virus) surface protein to ...

Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory ...

mAbs 2014; 6 (2):523-532). Cusatuzumab is currently being evaluated in patients ... Cusatuzumab is a first-in-class high-affinity humanized monoclonal antibody targeting CD70, an immune checkpoint ...

Oppenheimer began coverage on shares of Y-mAbs Therapeutics (NASDAQ:YMAB – Free Report) in a research note issued to ...

Stock recommendation on SIGA Technologies affected by mpox outbreak response, diversifying into mAbs for orthopoxviruses, remains speculative buy.

Bluejay Therapeutics, a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral ...

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.

Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.